← Eichor
Study identifier: NCT06929533 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Pharmacogenomics-Supported Psychotropic Prescribing Trial

Condition: Mental Disorder · Pharmacogenetics · Adverse Drug Reaction (ADR)  ·  Sponsor: University of Manitoba

PhaseNA
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Investigate the feasibility and utility of implementing pharmacogenetic testing for adults (aged 18 and older) seeking care for mental illness in Manitoba.

This description comes directly from the study's public registry record.

Talk to the study team

Abdullah Al Maruf, BPharm, MPharm, PhD  ·  204-318-2575  ·  abdullah.maruf@umanitoba.ca

Always discuss trial participation with your own doctor first.

Locations (2)

Shared Health FacilitiesWinnipeg, Manitoba, CanadaNot Yet Recruiting
University of Manitoba College of PharmacyWinnipeg, Manitoba, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06929533